author-photo

Tom Jay Parry

Johnson & Johnson Pharmaceutical Research and Development

16

Papers

271

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis.

2011 Blood Coagulation & Fibrinolysis
Show All
- Source
- Cite
- Save
Citations (8)
Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition.

2010 Journal of Cardiovascular Pharmacology
Show All
- Source
- Cite
- Save
Citations (45)
Torcetrapib Produces Endothelial Dysfunction Independent of CETP Inhibition

2009 Journal of Cardiovascular Pharmacology
Show All
- Source
- Cite
- Save
Citations (1)
Nonpeptide Urotensin-II Receptor Antagonists: A New Ligand Class Based on Piperazino-Phthalimide and Piperazino-Isoindolinone Subunits

2009 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (59)
Urotensin‐II Induces Ear Flushing in Rats

2009 British Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (8)
RESEARCH PAPER Urotensin-II Induces Ear Flushing in Rats

2007
Show All
- Source
- Cite
- Save
Citations (0)
Rivaroxaban — An Oral, Direct Factor Xa Inhibitor — Prevents Arterial Thrombotic Occlusion in Electrolytically Injured Rat Carotid Arteries.

2007 Blood
Show All
- Source
- Cite
- Save
Citations (3)
脈管の傷害後の再狭窄を防ぐための、ｐｉ３キナーゼ抑制因子の、単独の、あるいは、シロリムスとの組み合わせにおける、局所脈管送達

2006
Show All
- Source
- Cite
- Save
Citations (0)
Coating for medical devices with PI 3-kinase inhibitor

2006
Show All
- Source
- Cite
- Save
Citations (0)
Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries

2005 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (102)